{"gene":"MAN2A2","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1995,"finding":"MAN2A2 (alpha-mannosidase IIx) was identified as an isozyme of Golgi alpha-mannosidase II (MAN2A1). COS cells transfected with the full-length MAN2A2 cDNA (1139 amino acids) showed increased alpha-mannosidase activity, establishing it as an active enzyme involved in N-linked glycan processing. The gene was mapped to human chromosome 15q25.","method":"cDNA cloning, PCR, COS cell transfection with alpha-mannosidase activity assay, chromosomal mapping","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct enzymatic activity demonstrated in transfected cells, full-length cDNA characterized with activity assay","pmids":["8524845"],"is_preprint":false},{"year":1996,"finding":"The MAN2A2 promoter lacks canonical TATA/CAAT boxes but contains a CpG island and an Sp1-like binding site (GGGCGT at -12 to -7). Luciferase reporter assays identified the core promoter region (-12 to +11) and upstream enhancer elements (-4300 to -252) governing transcriptional regulation of MAN2A2.","method":"Primer extension analysis, luciferase reporter/transient expression assays in human melanoma G-361 cells, cosmid clone characterization","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter mapping with reporter assays and multiple deletion constructs, single lab","pmids":["9022667"],"is_preprint":false},{"year":2002,"finding":"Targeted disruption of Man2a2 in male mice caused infertility due to failure of spermatogenic cell adhesion to Sertoli cells and premature release of germ cells from the testis. Wild-type testes contained GlcNAc-terminated complex-type N-glycans that were significantly reduced in Man2a2-null testes. A purified GlcNAc-terminated tri-antennary, fucosylated N-glycan was identified as the specific carbohydrate structure mediating germ cell–Sertoli cell adhesion in vitro.","method":"Gene targeting/knockout mouse, histology, electron microscopy, quantitative N-glycan structural analysis, in vitro spermatogenic cell-Sertoli cell adhesion assay with purified N-glycan oligosaccharides","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (KO mouse, glycan structural analysis, in vitro adhesion reconstitution with purified glycans), replicated across two papers from same group","pmids":["11778047","12417422"],"is_preprint":false},{"year":2002,"finding":"In vitro enzymatic activity of MAN2A2 (alpha-mannosidase IIx) is minimal, yet the enzyme plays an essential in vivo role in generating GlcNAc-terminated complex N-glycans in testis, demonstrating a functional divergence between in vitro and in vivo activity.","method":"In vitro enzyme activity assay, N-glycan structural analysis from wild-type vs. Man2a2 knockout mouse testis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct in vitro assay combined with in vivo glycan analysis from KO mouse, single lab","pmids":["12417422"],"is_preprint":false},{"year":2019,"finding":"MAN2A2 acts as a central hub in multi-enzyme assemblies in Golgi membranes, forming distinct molecular complexes with MGAT1, MGAT2, MGAT3, and MGAT4B (but not MGAT5), as detected by high-throughput FRET- and BiFC-based interaction screens in living cells.","method":"High-throughput FRET-based interaction screen, BiFC (bimolecular fluorescence complementation), in vivo BiFC-based FRET in HEK cells","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal live-cell interaction methods (FRET, BiFC) in single lab","pmids":["30737517"],"is_preprint":false},{"year":2021,"finding":"Knockout of both MAN2A1 and MAN2A2 in HEK293 cells (M2D-KO) abolished complex-type N-glycan formation, resulting in recombinant proteins carrying predominantly hybrid-type N-glycans, establishing that MAN2A1 and MAN2A2 together are required for the conversion from hybrid- to complex-type N-glycans in this cell line.","method":"CRISPR/Cas9 double knockout, glycan structural analysis of recombinant proteins by mass spectrometry","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct glycan structural analysis of KO cells, but single lab and combined KO does not isolate MAN2A2-specific contribution","pmids":["33878161"],"is_preprint":false},{"year":2022,"finding":"A homozygous truncating variant p.Val1101Ter in MAN2A2 in humans causes a congenital disorder of glycosylation (CDG) with neurological involvement. Patient-derived lymphoblasts showed decreased complex N-glycans and accumulation of hybrid N-glycans. A cell-based complementation assay using MAN2A1/MAN2A2 double-knockout HEK293 cells confirmed complete loss of complex N-glycan production by this variant.","method":"Exome sequencing, Sanger sequencing, N-glycan analysis in patient lymphoblasts, cell-based complementation assay in MAN2A1/MAN2A2 double-KO HEK293 cells","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct glycan structural analysis in patient cells plus functional complementation assay with KO cell lines, multiple orthogonal methods","pmids":["36357165"],"is_preprint":false},{"year":2024,"finding":"Man2a2 inactivation in mice blocks spermatogenesis, and genetic epistasis analysis shows that MAN2A2 mannosidase generates the substrate for MGAT2 GlcNAc-transferase to form biantennary complex N-glycans required for spermatogenesis; loss of Mgat2 in spermatogonia causes a spermatogenic block phenotypically distinct from Man2a2 loss, indicating distinct pathway functions despite shared substrate relationships.","method":"Conditional knockout (Stra8-iCre-driven Mgat2 deletion), lectin-binding assays (L-PHA, GSA-II), RNA-seq, Western blot for AKT and ERK1/2 signaling, genetic epistasis comparison with Man2a2 and Mgat1 knockouts","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistatic pathway positioning via conditional KO comparisons with multiple molecular readouts, single lab","pmids":["39364139"],"is_preprint":false},{"year":2025,"finding":"Compound heterozygous variants in MAN2A2 (p.Arg560Gln in the alpha-mannosidase middle functional domain and p.Gln1098Ter) in a patient with autism spectrum disorder and cognitive delay resulted in impaired N-glycosylation with accumulation of hybrid-type N-glycans in serum, linking MAN2A2 enzymatic function in the Golgi to neurological development.","method":"Whole-exome sequencing, glycosylation analysis of serum glycoprotein N-glycans, structural prediction analyses","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct glycan analysis in patient sample with variant characterization; structural predictions are in silico only, single case","pmids":["40628855"],"is_preprint":false}],"current_model":"MAN2A2 (alpha-mannosidase IIx) is a Golgi-resident enzyme that trims mannose residues from N-glycan intermediates to generate the substrate for MGAT2, thereby enabling conversion of hybrid- to complex-type N-glycans; it has minimal in vitro activity but is essential in vivo—particularly in the testis where it produces a GlcNAc-terminated tri-antennary fucosylated N-glycan required for germ cell–Sertoli cell adhesion and spermatogenesis—and it acts as a central hub within multi-enzyme Golgi complexes (with MGAT1–4B); loss-of-function variants in humans cause a congenital disorder of glycosylation with neurological involvement."},"narrative":{"mechanistic_narrative":"MAN2A2 (alpha-mannosidase IIx) is a Golgi-resident glycan-processing enzyme that trims mannose residues from N-glycan intermediates during the maturation of N-linked glycans, functioning as an isozyme of Golgi alpha-mannosidase II [PMID:8524845]. Although its intrinsic in vitro mannosidase activity is minimal, MAN2A2 is essential in vivo for generating the GlcNAc-terminated complex-type N-glycans that depend on its activity [PMID:8524845, PMID:12417422]. Together with MAN2A1, MAN2A2 is required for the conversion of hybrid- to complex-type N-glycans, since loss of both enzymes abolishes complex N-glycan formation and traps proteins as hybrid-type [PMID:33878161]. Within the Golgi, MAN2A2 organizes glycan processing as a central hub in multi-enzyme assemblies, forming distinct complexes with MGAT1, MGAT2, MGAT3, and MGAT4B [PMID:30737517], and it generates the substrate acted on downstream by MGAT2 [PMID:39364139]. The enzyme is critically required for male fertility: its loss in mice blocks spermatogenesis by depleting a GlcNAc-terminated tri-antennary fucosylated N-glycan that mediates germ cell–Sertoli cell adhesion [PMID:11778047, PMID:12417422, PMID:39364139]. In humans, loss-of-function and compound heterozygous variants in MAN2A2 cause a congenital disorder of glycosylation with neurological involvement, characterized by reduced complex N-glycans and accumulation of hybrid-type N-glycans [PMID:36357165, PMID:40628855].","teleology":[{"year":1995,"claim":"Established MAN2A2 as a distinct, catalytically active alpha-mannosidase II isozyme acting in N-glycan processing, answering whether the gene encoded a functional glycosidase.","evidence":"cDNA cloning and COS cell transfection with alpha-mannosidase activity assay, plus chromosomal mapping to 15q25","pmids":["8524845"],"confidence":"High","gaps":["In vivo substrate and physiological role not addressed","Subcellular localization within the Golgi not directly demonstrated here"]},{"year":1996,"claim":"Defined the transcriptional architecture of MAN2A2 by mapping its TATA-less, CpG-island promoter and regulatory elements, clarifying how the gene is expressed.","evidence":"Primer extension and luciferase reporter assays with deletion constructs in human melanoma cells","pmids":["9022667"],"confidence":"Medium","gaps":["Tissue-specific regulation not resolved","Trans-acting factors beyond an Sp1-like site not identified"]},{"year":2002,"claim":"Revealed the essential in vivo function of MAN2A2 in spermatogenesis and identified the specific glycan it produces, despite minimal in vitro activity, resolving the paradox between weak biochemical activity and biological importance.","evidence":"Man2a2 knockout mice with histology, electron microscopy, N-glycan structural analysis, in vitro adhesion reconstitution with purified glycans, and direct in vitro enzyme assay","pmids":["11778047","12417422"],"confidence":"High","gaps":["Mechanism reconciling minimal in vitro activity with essential in vivo role not fully explained","Whether Sertoli cell receptor for the adhesion glycan is identified is unaddressed"]},{"year":2019,"claim":"Positioned MAN2A2 as an organizing hub of Golgi glycosylation machinery by mapping its physical partnerships with specific GlcNAc-transferases, addressing how processing enzymes are spatially coordinated.","evidence":"High-throughput FRET- and BiFC-based live-cell interaction screens in HEK cells","pmids":["30737517"],"confidence":"Medium","gaps":["Functional consequence of each complex on glycan output not measured","Stoichiometry and structural basis of the assemblies unknown","Single-lab live-cell methods without orthogonal biochemical validation"]},{"year":2021,"claim":"Demonstrated that MAN2A1 and MAN2A2 together are required for the hybrid-to-complex N-glycan transition in human cells, defining their combined pathway necessity.","evidence":"CRISPR/Cas9 double knockout in HEK293 cells with mass spectrometry glycan analysis of recombinant proteins","pmids":["33878161"],"confidence":"Medium","gaps":["Combined knockout does not isolate the MAN2A2-specific contribution","Single cell line and single lab"]},{"year":2022,"claim":"Linked MAN2A2 loss-of-function to a human congenital disorder of glycosylation, establishing direct clinical relevance of the enzyme's glycan-processing role.","evidence":"Exome sequencing identifying p.Val1101Ter, patient lymphoblast N-glycan analysis, and complementation in MAN2A1/MAN2A2 double-KO HEK293 cells","pmids":["36357165"],"confidence":"High","gaps":["Genotype-phenotype spectrum across patients not defined","Mechanistic basis of neurological involvement not resolved"]},{"year":2024,"claim":"Placed MAN2A2 upstream of MGAT2 in a defined glycan-processing pathway during spermatogenesis through genetic epistasis, distinguishing the consequences of disrupting sequential steps.","evidence":"Conditional Mgat2 knockout, lectin-binding assays, RNA-seq, AKT/ERK signaling Western blots, and epistasis comparison with Man2a2 and Mgat1 knockouts","pmids":["39364139"],"confidence":"Medium","gaps":["Direct enzymatic substrate-product chain not biochemically reconstituted","Signaling consequences downstream of altered glycosylation incompletely defined","Single lab"]},{"year":2025,"claim":"Extended the human phenotypic spectrum of MAN2A2 dysfunction to autism and cognitive delay via compound heterozygous variants, reinforcing the link between Golgi N-glycan processing and neurodevelopment.","evidence":"Whole-exome sequencing, serum glycoprotein N-glycan analysis, and in silico structural prediction","pmids":["40628855"],"confidence":"Medium","gaps":["Single case limits generalization","Structural predictions are in silico only and not experimentally validated","Causal link between glycan changes and neurodevelopmental phenotype not directly established"]},{"year":null,"claim":"How MAN2A2's minimal intrinsic catalytic activity is functionally amplified within Golgi multi-enzyme complexes to drive complex N-glycan formation in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No reconstituted biochemical mechanism explaining in vivo efficacy","Structural basis of MAN2A2–MGAT complexes unknown","Substrate channeling within Golgi assemblies not demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,5]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,8]}],"complexes":[],"partners":["MGAT1","MGAT2","MGAT3","MGAT4B","MAN2A1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49641","full_name":"Alpha-mannosidase 2x","aliases":["Alpha-mannosidase IIx","Man IIx","Mannosidase alpha class 2A member 2","Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase"],"length_aa":1150,"mass_kda":130.5,"function":"Catalyzes the first committed step in the biosynthesis of complex N-glycans. It controls conversion of high mannose to complex N-glycans; the final hydrolytic step in the N-glycan maturation pathway","subcellular_location":"Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/P49641/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAN2A2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MAN2A2","total_profiled":1310},"omim":[{"mim_id":"600988","title":"MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 2; MAN2A2","url":"https://www.omim.org/entry/600988"},{"mim_id":"154582","title":"MANNOSIDASE, ALPHA, CLASS 2A, MEMBER 1; MAN2A1","url":"https://www.omim.org/entry/154582"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytoplasmic bodies","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MAN2A2"},"hgnc":{"alias_symbol":["MANA2X","HsT19662","alpha-MIIx"],"prev_symbol":[]},"alphafold":{"accession":"P49641","domains":[{"cath_id":"3.20.110.10","chopping":"165-499","consensus_level":"medium","plddt":96.7776,"start":165,"end":499},{"cath_id":"2.70.98.30","chopping":"761-1023","consensus_level":"medium","plddt":94.1289,"start":761,"end":1023},{"cath_id":"2.60.40.1360","chopping":"1049-1150","consensus_level":"high","plddt":90.7389,"start":1049,"end":1150}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49641","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49641-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49641-F1-predicted_aligned_error_v6.png","plddt_mean":91.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAN2A2","jax_strain_url":"https://www.jax.org/strain/search?query=MAN2A2"},"sequence":{"accession":"P49641","fasta_url":"https://rest.uniprot.org/uniprotkb/P49641.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49641/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49641"}},"corpus_meta":[{"pmid":"11778047","id":"PMC_11778047","title":"Germ cell survival through carbohydrate-mediated interaction with Sertoli cells.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11778047","citation_count":117,"is_preprint":false},{"pmid":"31197173","id":"PMC_31197173","title":"An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31197173","citation_count":75,"is_preprint":false},{"pmid":"8524845","id":"PMC_8524845","title":"Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8524845","citation_count":70,"is_preprint":false},{"pmid":"30737517","id":"PMC_30737517","title":"N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme-multi-transporter assemblies in golgi membranes in vivo.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/30737517","citation_count":46,"is_preprint":false},{"pmid":"38591222","id":"PMC_38591222","title":"Exploring Genetic Associations of 3 Types of Risk Factors With Ischemic Stroke: An Integrated Bioinformatics Study.","date":"2024","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/38591222","citation_count":21,"is_preprint":false},{"pmid":"35163208","id":"PMC_35163208","title":"Identification of a Novel Theranostic Signature of Metabolic and Immune-Inflammatory Dysregulation in Myocardial Infarction, and the Potential Therapeutic Properties of Ovatodiolide, a Diterpenoid Derivative.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35163208","citation_count":18,"is_preprint":false},{"pmid":"12417422","id":"PMC_12417422","title":"In vivo role of alpha-mannosidase IIx: ineffective spermatogenesis resulting from targeted disruption of the Man2a2 in the mouse.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12417422","citation_count":16,"is_preprint":false},{"pmid":"33141432","id":"PMC_33141432","title":"High glucose-ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33141432","citation_count":13,"is_preprint":false},{"pmid":"30226535","id":"PMC_30226535","title":"Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30226535","citation_count":12,"is_preprint":false},{"pmid":"29343654","id":"PMC_29343654","title":"Intestinal Epithelial Cell-specific Deletion of α-Mannosidase II Ameliorates Experimental Colitis.","date":"2018","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/29343654","citation_count":10,"is_preprint":false},{"pmid":"33878161","id":"PMC_33878161","title":"Cell engineering for the production of hybrid-type N-glycans in HEK293 cells.","date":"2021","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33878161","citation_count":8,"is_preprint":false},{"pmid":"39827095","id":"PMC_39827095","title":"Longitudinal association between DNA methylation and type 2 diabetes: findings from the KORA F4/FF4 study.","date":"2025","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/39827095","citation_count":7,"is_preprint":false},{"pmid":"9022667","id":"PMC_9022667","title":"Structure and transcriptional regulation of human alpha-mannosidase IIX (alpha-mannosidase II isotype) gene.","date":"1996","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9022667","citation_count":6,"is_preprint":false},{"pmid":"36357165","id":"PMC_36357165","title":"Homozygous truncating variant in MAN2A2 causes a novel congenital disorder of glycosylation with neurological involvement.","date":"2022","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36357165","citation_count":4,"is_preprint":false},{"pmid":"40628855","id":"PMC_40628855","title":"MAN2A2-related glycosylation defects in autism and cognitive delay.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40628855","citation_count":4,"is_preprint":false},{"pmid":"40210651","id":"PMC_40210651","title":"Unique N-glycosylation signatures in human iPSC derived microglia activated by Aβ oligomer and lipopolysaccharide.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40210651","citation_count":4,"is_preprint":false},{"pmid":"41389538","id":"PMC_41389538","title":"Genome-wide association study of economic traits and functional characterization of MAN2A2 in the Jilin White Goose.","date":"2025","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/41389538","citation_count":2,"is_preprint":false},{"pmid":"39606433","id":"PMC_39606433","title":"Unique N-glycosylation signatures in Aβ oligomer-and lipopolysaccharide-activated human iPSC-derived microglia.","date":"2024","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/39606433","citation_count":1,"is_preprint":false},{"pmid":"38715006","id":"PMC_38715006","title":"Whole exome sequencing and proteomics-based investigation of the pathogenesis of coronary artery disease with diffuse long lesion.","date":"2024","source":"Journal of cardiothoracic surgery","url":"https://pubmed.ncbi.nlm.nih.gov/38715006","citation_count":1,"is_preprint":false},{"pmid":"38759877","id":"PMC_38759877","title":"Hypobaric hypoxia causes low fecundity in zebrafish parents and impairment of skeletal development in zebrafish embryos and rat offspring.","date":"2024","source":"Reproductive toxicology (Elmsford, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/38759877","citation_count":1,"is_preprint":false},{"pmid":"39364139","id":"PMC_39364139","title":"Deletion of Mgat2 in spermatogonia blocks spermatogenesis.","date":"2024","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/39364139","citation_count":0,"is_preprint":false},{"pmid":"41965819","id":"PMC_41965819","title":"Epigenome-wide Mendelian randomization with multi-omics validation identifies epigenetic drivers of idiopathic pulmonary fibrosis.","date":"2026","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41965819","citation_count":0,"is_preprint":false},{"pmid":"41590571","id":"PMC_41590571","title":"Does Altered Membrane Glycosylation Contribute to Neurodevelopmental Dysfunction in Autism Spectrum Disorder?","date":"2026","source":"Membranes","url":"https://pubmed.ncbi.nlm.nih.gov/41590571","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14338,"output_tokens":2498,"usd":0.040242,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9649,"output_tokens":2950,"usd":0.060998,"stage2_stop_reason":"end_turn"},"total_usd":0.10124,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"MAN2A2 (alpha-mannosidase IIx) was identified as an isozyme of Golgi alpha-mannosidase II (MAN2A1). COS cells transfected with the full-length MAN2A2 cDNA (1139 amino acids) showed increased alpha-mannosidase activity, establishing it as an active enzyme involved in N-linked glycan processing. The gene was mapped to human chromosome 15q25.\",\n      \"method\": \"cDNA cloning, PCR, COS cell transfection with alpha-mannosidase activity assay, chromosomal mapping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct enzymatic activity demonstrated in transfected cells, full-length cDNA characterized with activity assay\",\n      \"pmids\": [\"8524845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The MAN2A2 promoter lacks canonical TATA/CAAT boxes but contains a CpG island and an Sp1-like binding site (GGGCGT at -12 to -7). Luciferase reporter assays identified the core promoter region (-12 to +11) and upstream enhancer elements (-4300 to -252) governing transcriptional regulation of MAN2A2.\",\n      \"method\": \"Primer extension analysis, luciferase reporter/transient expression assays in human melanoma G-361 cells, cosmid clone characterization\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter mapping with reporter assays and multiple deletion constructs, single lab\",\n      \"pmids\": [\"9022667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Targeted disruption of Man2a2 in male mice caused infertility due to failure of spermatogenic cell adhesion to Sertoli cells and premature release of germ cells from the testis. Wild-type testes contained GlcNAc-terminated complex-type N-glycans that were significantly reduced in Man2a2-null testes. A purified GlcNAc-terminated tri-antennary, fucosylated N-glycan was identified as the specific carbohydrate structure mediating germ cell–Sertoli cell adhesion in vitro.\",\n      \"method\": \"Gene targeting/knockout mouse, histology, electron microscopy, quantitative N-glycan structural analysis, in vitro spermatogenic cell-Sertoli cell adhesion assay with purified N-glycan oligosaccharides\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (KO mouse, glycan structural analysis, in vitro adhesion reconstitution with purified glycans), replicated across two papers from same group\",\n      \"pmids\": [\"11778047\", \"12417422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In vitro enzymatic activity of MAN2A2 (alpha-mannosidase IIx) is minimal, yet the enzyme plays an essential in vivo role in generating GlcNAc-terminated complex N-glycans in testis, demonstrating a functional divergence between in vitro and in vivo activity.\",\n      \"method\": \"In vitro enzyme activity assay, N-glycan structural analysis from wild-type vs. Man2a2 knockout mouse testis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro assay combined with in vivo glycan analysis from KO mouse, single lab\",\n      \"pmids\": [\"12417422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MAN2A2 acts as a central hub in multi-enzyme assemblies in Golgi membranes, forming distinct molecular complexes with MGAT1, MGAT2, MGAT3, and MGAT4B (but not MGAT5), as detected by high-throughput FRET- and BiFC-based interaction screens in living cells.\",\n      \"method\": \"High-throughput FRET-based interaction screen, BiFC (bimolecular fluorescence complementation), in vivo BiFC-based FRET in HEK cells\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal live-cell interaction methods (FRET, BiFC) in single lab\",\n      \"pmids\": [\"30737517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Knockout of both MAN2A1 and MAN2A2 in HEK293 cells (M2D-KO) abolished complex-type N-glycan formation, resulting in recombinant proteins carrying predominantly hybrid-type N-glycans, establishing that MAN2A1 and MAN2A2 together are required for the conversion from hybrid- to complex-type N-glycans in this cell line.\",\n      \"method\": \"CRISPR/Cas9 double knockout, glycan structural analysis of recombinant proteins by mass spectrometry\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct glycan structural analysis of KO cells, but single lab and combined KO does not isolate MAN2A2-specific contribution\",\n      \"pmids\": [\"33878161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A homozygous truncating variant p.Val1101Ter in MAN2A2 in humans causes a congenital disorder of glycosylation (CDG) with neurological involvement. Patient-derived lymphoblasts showed decreased complex N-glycans and accumulation of hybrid N-glycans. A cell-based complementation assay using MAN2A1/MAN2A2 double-knockout HEK293 cells confirmed complete loss of complex N-glycan production by this variant.\",\n      \"method\": \"Exome sequencing, Sanger sequencing, N-glycan analysis in patient lymphoblasts, cell-based complementation assay in MAN2A1/MAN2A2 double-KO HEK293 cells\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct glycan structural analysis in patient cells plus functional complementation assay with KO cell lines, multiple orthogonal methods\",\n      \"pmids\": [\"36357165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Man2a2 inactivation in mice blocks spermatogenesis, and genetic epistasis analysis shows that MAN2A2 mannosidase generates the substrate for MGAT2 GlcNAc-transferase to form biantennary complex N-glycans required for spermatogenesis; loss of Mgat2 in spermatogonia causes a spermatogenic block phenotypically distinct from Man2a2 loss, indicating distinct pathway functions despite shared substrate relationships.\",\n      \"method\": \"Conditional knockout (Stra8-iCre-driven Mgat2 deletion), lectin-binding assays (L-PHA, GSA-II), RNA-seq, Western blot for AKT and ERK1/2 signaling, genetic epistasis comparison with Man2a2 and Mgat1 knockouts\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistatic pathway positioning via conditional KO comparisons with multiple molecular readouts, single lab\",\n      \"pmids\": [\"39364139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Compound heterozygous variants in MAN2A2 (p.Arg560Gln in the alpha-mannosidase middle functional domain and p.Gln1098Ter) in a patient with autism spectrum disorder and cognitive delay resulted in impaired N-glycosylation with accumulation of hybrid-type N-glycans in serum, linking MAN2A2 enzymatic function in the Golgi to neurological development.\",\n      \"method\": \"Whole-exome sequencing, glycosylation analysis of serum glycoprotein N-glycans, structural prediction analyses\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct glycan analysis in patient sample with variant characterization; structural predictions are in silico only, single case\",\n      \"pmids\": [\"40628855\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAN2A2 (alpha-mannosidase IIx) is a Golgi-resident enzyme that trims mannose residues from N-glycan intermediates to generate the substrate for MGAT2, thereby enabling conversion of hybrid- to complex-type N-glycans; it has minimal in vitro activity but is essential in vivo—particularly in the testis where it produces a GlcNAc-terminated tri-antennary fucosylated N-glycan required for germ cell–Sertoli cell adhesion and spermatogenesis—and it acts as a central hub within multi-enzyme Golgi complexes (with MGAT1–4B); loss-of-function variants in humans cause a congenital disorder of glycosylation with neurological involvement.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAN2A2 (alpha-mannosidase IIx) is a Golgi-resident glycan-processing enzyme that trims mannose residues from N-glycan intermediates during the maturation of N-linked glycans, functioning as an isozyme of Golgi alpha-mannosidase II [#0]. Although its intrinsic in vitro mannosidase activity is minimal, MAN2A2 is essential in vivo for generating the GlcNAc-terminated complex-type N-glycans that depend on its activity [#0, #3]. Together with MAN2A1, MAN2A2 is required for the conversion of hybrid- to complex-type N-glycans, since loss of both enzymes abolishes complex N-glycan formation and traps proteins as hybrid-type [#5]. Within the Golgi, MAN2A2 organizes glycan processing as a central hub in multi-enzyme assemblies, forming distinct complexes with MGAT1, MGAT2, MGAT3, and MGAT4B [#4], and it generates the substrate acted on downstream by MGAT2 [#7]. The enzyme is critically required for male fertility: its loss in mice blocks spermatogenesis by depleting a GlcNAc-terminated tri-antennary fucosylated N-glycan that mediates germ cell–Sertoli cell adhesion [#2, #7]. In humans, loss-of-function and compound heterozygous variants in MAN2A2 cause a congenital disorder of glycosylation with neurological involvement, characterized by reduced complex N-glycans and accumulation of hybrid-type N-glycans [#6, #8].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established MAN2A2 as a distinct, catalytically active alpha-mannosidase II isozyme acting in N-glycan processing, answering whether the gene encoded a functional glycosidase.\",\n      \"evidence\": \"cDNA cloning and COS cell transfection with alpha-mannosidase activity assay, plus chromosomal mapping to 15q25\",\n      \"pmids\": [\"8524845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo substrate and physiological role not addressed\", \"Subcellular localization within the Golgi not directly demonstrated here\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined the transcriptional architecture of MAN2A2 by mapping its TATA-less, CpG-island promoter and regulatory elements, clarifying how the gene is expressed.\",\n      \"evidence\": \"Primer extension and luciferase reporter assays with deletion constructs in human melanoma cells\",\n      \"pmids\": [\"9022667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue-specific regulation not resolved\", \"Trans-acting factors beyond an Sp1-like site not identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed the essential in vivo function of MAN2A2 in spermatogenesis and identified the specific glycan it produces, despite minimal in vitro activity, resolving the paradox between weak biochemical activity and biological importance.\",\n      \"evidence\": \"Man2a2 knockout mice with histology, electron microscopy, N-glycan structural analysis, in vitro adhesion reconstitution with purified glycans, and direct in vitro enzyme assay\",\n      \"pmids\": [\"11778047\", \"12417422\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism reconciling minimal in vitro activity with essential in vivo role not fully explained\", \"Whether Sertoli cell receptor for the adhesion glycan is identified is unaddressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Positioned MAN2A2 as an organizing hub of Golgi glycosylation machinery by mapping its physical partnerships with specific GlcNAc-transferases, addressing how processing enzymes are spatially coordinated.\",\n      \"evidence\": \"High-throughput FRET- and BiFC-based live-cell interaction screens in HEK cells\",\n      \"pmids\": [\"30737517\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of each complex on glycan output not measured\", \"Stoichiometry and structural basis of the assemblies unknown\", \"Single-lab live-cell methods without orthogonal biochemical validation\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated that MAN2A1 and MAN2A2 together are required for the hybrid-to-complex N-glycan transition in human cells, defining their combined pathway necessity.\",\n      \"evidence\": \"CRISPR/Cas9 double knockout in HEK293 cells with mass spectrometry glycan analysis of recombinant proteins\",\n      \"pmids\": [\"33878161\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Combined knockout does not isolate the MAN2A2-specific contribution\", \"Single cell line and single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked MAN2A2 loss-of-function to a human congenital disorder of glycosylation, establishing direct clinical relevance of the enzyme's glycan-processing role.\",\n      \"evidence\": \"Exome sequencing identifying p.Val1101Ter, patient lymphoblast N-glycan analysis, and complementation in MAN2A1/MAN2A2 double-KO HEK293 cells\",\n      \"pmids\": [\"36357165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype spectrum across patients not defined\", \"Mechanistic basis of neurological involvement not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed MAN2A2 upstream of MGAT2 in a defined glycan-processing pathway during spermatogenesis through genetic epistasis, distinguishing the consequences of disrupting sequential steps.\",\n      \"evidence\": \"Conditional Mgat2 knockout, lectin-binding assays, RNA-seq, AKT/ERK signaling Western blots, and epistasis comparison with Man2a2 and Mgat1 knockouts\",\n      \"pmids\": [\"39364139\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic substrate-product chain not biochemically reconstituted\", \"Signaling consequences downstream of altered glycosylation incompletely defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended the human phenotypic spectrum of MAN2A2 dysfunction to autism and cognitive delay via compound heterozygous variants, reinforcing the link between Golgi N-glycan processing and neurodevelopment.\",\n      \"evidence\": \"Whole-exome sequencing, serum glycoprotein N-glycan analysis, and in silico structural prediction\",\n      \"pmids\": [\"40628855\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case limits generalization\", \"Structural predictions are in silico only and not experimentally validated\", \"Causal link between glycan changes and neurodevelopmental phenotype not directly established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MAN2A2's minimal intrinsic catalytic activity is functionally amplified within Golgi multi-enzyme complexes to drive complex N-glycan formation in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstituted biochemical mechanism explaining in vivo efficacy\", \"Structural basis of MAN2A2–MGAT complexes unknown\", \"Substrate channeling within Golgi assemblies not demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MGAT1\", \"MGAT2\", \"MGAT3\", \"MGAT4B\", \"MAN2A1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":6,"faith_pct":100.0}}